drugset / Trial / NCT04829903

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

NCT04829903

Completed 116 enrolled Corporacion Parc Tauli
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

Timeline

Start
2020-01-02
Primary completion
2021-03-29
Completion
2021-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dulaglutide Peptide
Comparator Liraglutide Peptide